Tackling the latest COVID-19 topics
Medical research reveals new information about COVID-19 daily. While scientists and medical experts focus on virus spread, new variants, improved therapeutic treatments and more, it's sometimes difficult for the public to keep up with evolving information.
In this Mayo Clinic Q&A podcast, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, helps by answering a number of common questions and addressing these COVID-19 topics:
- Antibody tests after having a COVID-19 vaccine.
- Monoclonal antibodies.
- COVID-19 variants.
- Side effects, especially after the second dose of a COVID-19 vaccine.
- Vaccinating children and attending school in person.
- Whether COVID-19 vaccines an be interchanged.
- Mask-wearing recommendations.
- Appearance of long-hauler symptoms are more often in women.
- Pregnant, breastfeeding mothers and the COVID-19 vaccines.
To practice safe social distancing during the COVID-19 pandemic, this interview was conducted using video conferencing. The sound and video quality are representative of the technology used. For the safety of its patients, staff and visitors, Mayo Clinic has strict masking policies in place. Anyone shown without a mask was recorded prior to COVID-19 or recorded in an area not designated for patient care, where social distancing and other safety protocols were followed.
See full transcript.
Connect with others talking about the pandemic and supporting one another in the COVID-19 support group.
Information in this post was accurate at the time of its posting. Due to the fluid nature of the COVID-19 pandemic, scientific understanding, along with guidelines and recommendations, may have changed since the original publication date.
Dr. Poland has served as a consultant for Merck & Co. Inc., Medicago Inc., GlaxoSmithKline plc, Sanofi Pasteur, Emergent BioSolutions Inc., Dynavax Technologies Corp., Genentech Inc., Eli Lilly and Co., Kentucky BioProcessing Inc. and Genevant Sciences Corp., and Janssen Pharmaceuticals Inc. He is a paid scientific adviser for Johnson & Johnson. Honoraria: Elsevier.